A detailed history of Lazard Asset Management LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 1,840,452 shares of TMO stock, worth $1.02 Billion. This represents 1.3% of its overall portfolio holdings.

Number of Shares
1,840,452
Previous 1,877,702 1.98%
Holding current value
$1.02 Billion
Previous $997 Million 7.33%
% of portfolio
1.3%
Previous 1.37%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$528.82 - $599.43 $19.7 Million - $22.3 Million
-37,250 Reduced 1.98%
1,840,452 $1.07 Billion
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $14.8 Million - $18.3 Million
-34,255 Reduced 1.79%
1,877,702 $997 Million
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $24.9 Million - $28.7 Million
-49,969 Reduced 2.55%
1,911,957 $968 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $20.1 Million - $23.4 Million
39,591 Added 2.06%
1,961,926 $1.02 Billion
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $24.8 Million - $28 Million
46,298 Added 2.47%
1,922,335 $1.11 Billion
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $1.43 Million - $1.68 Million
-2,947 Reduced 0.16%
1,876,037 $1.03 Billion
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $17.5 Million - $20.8 Million
-34,465 Reduced 1.8%
1,878,984 $953 Million
Q2 2022

Aug 09, 2022

SELL
$500.9 - $612.21 $25.5 Million - $31.2 Million
-50,954 Reduced 2.59%
1,913,449 $1.04 Billion
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $48.3 Million - $59.5 Million
-92,209 Reduced 4.48%
1,964,403 $1.16 Billion
Q4 2021

Feb 09, 2022

SELL
$569.0 - $667.24 $17.2 Million - $20.2 Million
-30,274 Reduced 1.45%
2,056,612 $1.37 Billion
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $19.8 Million - $23.7 Million
-38,810 Reduced 1.83%
2,086,886 $1.19 Billion
Q2 2021

Aug 12, 2021

BUY
$441.0 - $508.24 $70 Million - $80.7 Million
158,778 Added 8.07%
2,125,696 $1.07 Billion
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $5.78 Million - $6.82 Million
-13,150 Reduced 0.66%
1,966,918 $898 Million
Q4 2020

Feb 11, 2021

BUY
$435.06 - $527.66 $8.44 Million - $10.2 Million
19,391 Added 0.99%
1,980,068 $922 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $44.4 Million - $54.5 Million
-123,337 Reduced 5.92%
1,960,677 $866 Million
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $82.6 Million - $109 Million
300,277 Added 16.83%
2,084,014 $755 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $750,837 - $1 Million
-2,941 Reduced 0.16%
1,783,737 $506 Million
Q4 2019

Feb 13, 2020

BUY
$271.93 - $328.04 $13.8 Million - $16.6 Million
50,694 Added 2.92%
1,786,678 $580 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $50.4 Million - $57.3 Million
-187,714 Reduced 9.76%
1,735,984 $506 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $89.5 Million - $103 Million
-347,706 Reduced 15.31%
1,923,698 $565 Million
Q1 2019

Aug 28, 2019

SELL
$212.17 - $273.72 $11,669 - $15,054
-55 Reduced -0.0%
2,271,404 $622 Million
Q1 2019

May 13, 2019

BUY
$212.17 - $273.72 $15.7 Million - $20.2 Million
73,901 Added 3.36%
2,271,459 $622 Million
Q4 2018

Aug 28, 2019

BUY
$208.47 - $251.98 $24.6 Million - $29.8 Million
118,071 Added 5.68%
2,197,558 $492 Million
Q4 2018

Feb 13, 2019

BUY
$208.47 - $251.98 $34.3 Million - $41.5 Million
164,502 Added 8.59%
2,079,487 $465 Million
Q3 2018

Aug 30, 2019

BUY
$205.57 - $244.32 $24 Million - $28.5 Million
116,719 Added 6.49%
1,914,985 $467 Million
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $69.7 Million - $82.9 Million
339,228 Added 23.25%
1,798,266 $439 Million
Q2 2018

Aug 30, 2019

BUY
$203.14 - $219.53 $20.3 Million - $22 Million
100,103 Added 7.37%
1,459,038 $302 Million
Q2 2018

Aug 13, 2018

SELL
$203.14 - $219.53 $16 Million - $17.2 Million
-78,535 Reduced 5.46%
1,358,935 $281 Million
Q1 2018

Aug 28, 2019

BUY
$192.98 - $224.11 $18.8 Million - $21.8 Million
97,229 Added 7.25%
1,437,470 $297 Million
Q1 2018

May 14, 2018

BUY
$192.98 - $224.11 $5.29 Million - $6.14 Million
27,402 Added 2.09%
1,340,241 $277 Million
Q4 2017

Aug 28, 2019

BUY
$182.03 - $200.37 $16 Million - $17.6 Million
87,805 Added 7.17%
1,312,839 $249 Million
Q4 2017

Feb 13, 2018

BUY
$182.03 - $200.37 $12.2 Million - $13.4 Million
66,989 Added 5.78%
1,225,034 $233 Million
Q3 2017

Aug 19, 2019

BUY
$171.74 - $194.04 $14.9 Million - $16.8 Million
86,718 Added 8.09%
1,158,045 $219 Million
Q3 2017

Nov 13, 2017

SELL
$171.74 - $194.04 $13.7 Million - $15.5 Million
-79,929 Reduced 6.94%
1,071,327 $203 Million
Q2 2017

Aug 19, 2019

BUY
N/A
61,943 Added 5.69%
1,151,256 $201 Million
Q1 2017

Aug 13, 2019

SELL
N/A
-1,577 Reduced 0.14%
1,089,313 $167 Million
Q4 2016

Jul 30, 2019

SELL
N/A
-344,826 Reduced 24.02%
1,090,890 $154 Million
Q3 2016

Aug 07, 2019

SELL
N/A
-80,178 Reduced 5.29%
1,435,716 $228 Million
Q2 2016

Jul 29, 2019

SELL
N/A
-272,116 Reduced 15.22%
1,515,894 $224 Million
Q1 2016

Jul 25, 2019

BUY
N/A
283,873 Added 18.87%
1,788,010 $253 Million
Q4 2015

Jul 24, 2019

BUY
N/A
452,609 Added 43.04%
1,504,137 $213 Million
Q3 2015

Jul 15, 2019

BUY
N/A
320,800 Added 43.9%
1,051,528 $129 Million
Q2 2015

Jul 08, 2019

BUY
N/A
149,156 Added 25.65%
730,728 $94.8 Million
Q4 2014

Aug 29, 2019

BUY
N/A
581,572
581,572 $72.9 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $217B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.